Schedule 13D ownership disclosure

ADC THERAPEUTICS SA

Security class unavailable · CUSIP: H0036K147

Event date: 2022-12-08

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
23.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001011438-22-000284
Form type
SC 13D/A
Filer
ADC Therapeutics SA
CIK
CIK 1771910
Filed
Dec 09, 2022
Reporting period
Dec 08, 2022
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub